Skip to main content

heartburn Archives

Zantac recalled for carcinogen levels above FDA standards

Nov. 27, 2019—The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer. The recall includes oral tablets, capsules, and syrup.

Read more


Surgical group works to expand heartburn treatment options

Dec. 19, 2017—For three years, 79-year-old Jerry Mock didn’t fully enjoy family vacations or gatherings with friends because his gastro-esophageal reflux disease (GERD) was so debilitating that eating even a bite of food after 1 p.m. guaranteed he’d have intense burning pain in his throat and chest that night.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more